Clinical Trials Support Services Market Set to Witness an Uptick during 2021 to 2028: Grand View Research Inc.

 Clinical Trials Support Services Market Growth & Trends

The global clinical trials support services market size is anticipated to reach USD 35.2 billion by 2028, according to the new report of Grand View Research, Inc., expanding at a CAGR of 7.3% over the forecast period. The factors driving market growth include rising demand for drug development that necessitates clinical trials and an increase in the number of CROs.

In the U.S., the biopharmaceutical sector contributes to around 90% of total spending on clinical trials for drugs and equipment. A clinical trial's costs include data management, patient recruiting, site recruitment, and clinical procedure expenditures. Pharmaceutical firms have been gradually expanding their R&D investment in recent years. This was mostly due to a patent cliff in 2012, which resulted from several patent expirations.

The outbreak of COVID-19 is further expected to enhance demand for clinical trial support services throughout the forecast period. The majority of enterprises and businesses across the world are under threat from the rapidly developing risk caused by the spread of the COVID-19 disease. The current pandemic represents a serious threat to the wellbeing of the whole population. A key to effectively fighting COVID-19 lies in clinical research. The current situation across the globe and the need to think of treatment options have additionally prompted the most optimized plan to led clinical trials.

Request a free sample copy or view report summary: Clinical Trials Support Services Market Report

Clinical Trials Support Services Market Report Highlights

• The phase III segment dominated the market with a revenue share of over 53% in 2020. This growth is attributed to the fact that phase III clinical trials are the most expensive ones and involve huge subjects
• The clinical trial site management service segment accounted for the maximum revenue share in 2020. Clinical trial site management services for managing offshore operations have seen tremendous expansion as a result of the trend of clinical trial outsourcing
• The pharmaceutical & biopharmaceutical companies sponsor segment led the market in 2020. The biopharmaceutical industry accounts for around 90% of total spending on clinical trials for medicines and equipment in the U.S.
• North America is set to lead the global market during the forecast years due to the increasing R&D spending, rising demand for medication development, strong governmental efforts, and current projects

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-trials-support-services-market

Clinical Trials Support Services Market Segmentation

Grand View Research has segmented the global clinical trials support services market on the basis of phase, service, sponsor, and region:

Clinical Trials Support Services Phase Outlook (Revenue, USD Million, 2016 - 2028)

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trials Support Service Outlook (Revenue, USD Million, 2016 - 2028)

• Clinical Trial Site Management
• Patient Recruitment Management
• Data Management
• Administrative Staff
• IRB
• Others

Clinical Trials Support Services Sponsor Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Others

Clinical Trials Support Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • France
  • UK.
  • Germany
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Trials Support Services Market

• Charles River Laboratories
• IQVIA
• Pharmaceutical Product Development LLC
• WuXi AppTec
• Parexel International
• Icon PLC
• Laboratory Corp. of America Holdings
• Novotech

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Semi-Autonomous Vehicle Market Expected To Trigger A Revenue To 60.1 Million Units By 2028: Grand View Research, Inc.

 Semi-Autonomous Vehicle Market Growth & Trends

The global semi-autonomous vehicle market demand is anticipated to reach 60.1 million units by 2028, exhibiting a CAGR of 20.8% over the forecast period, according to a new report by Grand View Research, Inc. The rapid growth can be attributed to the rising adoption of driver-assisted technologies, thereby enhancing the driving experience. The confluence of abilities such as electronic braking, adaptive cruise control, and obstacle detection; and continuous technological innovations happening in driving technologies offer an impetus to market growth. Semi-autonomous cars also promise drivers the ability to practice safer driving over the forecast period, thus driving higher adoption. The availability of forwarding collision and lane assistance and progressive learning models in cars helps to remove human error, thus reducing accidents.

The rising technological development of semi-autonomous cars has increased integration with connected technologies, thus increasing efficiency by minimizing human error. Semi-autonomous vehicles can increase the efficiency of vehicles as they would offer real-time traffic updates, enhanced driving assistance systems, and connected cars. Semi-automatic cars also offer the ability to indulge in intelligent driving, thus helping in changing routes accordingly. Thus, the vehicles would be more efficient and secure as they would not result in the wastage of fuel in traffic jams and ensure passenger safety.

Artificial Intelligence (AI) offers promising growth opportunities to the semi-autonomous cars market due to its applications in several use cases within automotive. The implementation of Ai-models aids in pattern and obstacle recognition, which helps understand verbal sounds, non-verbal cues, and gestures. There has been an increasing trend in the adoption of AI for steering mechanism which simplifies driving effort, enhances engine performance, and increase fuel efficiency.

The Asia Pacific region is expected to witness the fastest CAGR of 22.7%, followed by the Middle East and Africa and South America. The high growth rate can be attributed to a strong AI hub in China, Japan, Singapore, and India, enabling automotive players to gain easy access to automotive-specific AI programs and services. The rising economy of Middle Eastern countries also offers promising growth opportunities to the MEA region. This can be accredited to the rising disposable income of people in the region, increasing interest of people to leverage semi-autonomous vehicles for commercial and personal uses, and favorable government regulations which help in regulating market growth.

Request a free sample copy or view report summary: Semi-Autonomous Vehicle Market Report

Semi-Autonomous Vehicle Market Report Highlights

• The level 3 automation segment is expected to emerge as the fastest-growing segment over the forecast period. Level 3 automation offers technological advancement with environmental detection capabilities, capable of making informed decisions such as overtake slow-moving vehicles, traffic maneuverability, and smart obstacle detection
• The commercial vehicle segment is expected to register the highest CAGR over the forecast period. The deployment of semi-autonomous driving solution in commercial vehicles ensures safe movement of products and goods, thus allowing the driver to maintain good health and posture
• The Asia Pacific region is expected to dominate the market over the forecast period. This can be attributed to the presence of the AI hubs in countries such as China, Japan, Singapore, and India; which offers a conducive environment for the semi-autonomous market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-semi-autonomous-vehicle-market

Semi-Autonomous Vehicle Market Segmentation

Grand View Research has segmented the global semi-autonomous vehicle market based on level of automation, vehicle type, and region:

Semi-Autonomous Vehicle Level of Automation Outlook (Volume, Million Units, 2017 - 2028)

• Level 1
• Level 2
• Level 3

Semi-Autonomous Vehicle Type Outlook (Volume, Million Units, 2017 - 2028)

• Passenger Car
• Commercial Vehicle

Semi-Autonomous Vehicle Regional Outlook (Volume, Million Units, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• South America
  • Brazil
• MEA

List of Key Players of the Semi-Autonomous Vehicle Market

• Audi AG
• BMW AG
• Continental AG
• Diamler AG (Mercedes Benz)
• Ford Motor Company
• General Motors
• Honda Motor Company
• Nissan Motor Company
• Toyota Motor Corporation
• Volvo Car Corporation
• Valeo S.A.
• Volkswagen AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Skilled Nursing Facility And Rehabilitation Market Is Expected To Accomplish A Valuation Of Around USD 281.6 Billion By 2028: Grand View Research Inc.

 U.S. Skilled Nursing Facility And Rehabilitation Market Growth & Trends

The U.S. skilled nursing facility and rehabilitation market size is expected to reach USD 281.6 billion by 2028, expanding at a CAGR of 3.4%, according to a new report by Grand View Research, Inc. The growing incidences of chronic conditions such as diabetes, paralysis, and hypertension and the rising geriatric population are factors expected to fuel the market over the next few years. In 2019, the geriatric population over 65 has increased up to 9.0% out of which 14.3 majorities of adults above the age of 65 years suffered from chronic disease and need these facilities. Medicare and Medicaid availability and the growing technologies will play a driving role for the market in the coming years.

To cope with the COVID-19 situation, in November 2020, the Centers for Medicare and Medicaid Services released guidelines for skilled nursing facilities to help curb the spread of the novel COVID-19 infection. These measures include physical distancing (maintain a distance of 6 feet from people), wearing a face mask, and limiting the number of visitors (keeping it one at a time). Majority of these facilities were not allowed to accept new residents and did not have new revenue streams for the additional expenses associated with the virus, which had a negative impact on the sector.

Request a free sample copy or view report summary: U.S. Skilled Nursing Facility And Rehabilitation Market Report

U.S. Skilled Nursing Facility And Rehabilitation Market Report Highlights

• The freestanding segment dominated the market in 2020 due to its lower cost compared to the hospital-based facility. The segment is expected to continue its dominance and witness a significant growth rate over the forecast period
• Skilled nursing facilities are reimbursed by medicare part A and B resulting in more sustainability, thereby propelling the growth of the market
• The market includes small and large players, leading to higher competition among smaller players to sustain their market position. The market is quite open for new entrants due to government support and great reimbursement policies
• Mergers and acquisitions are key strategic initiatives undertaken by market players to sustain in the competitive market. For instance, in December 2020, The Ensign Group, Inc. acquired Hays Nursing and Rehabilitation Center, a 116-bed skilled nursing facility located in Texas
• To provide skilled nursing and rehabilitation service during the COVID-19 pandemic, many skilled nursing and rehabilitation facilities came up with remote programs to serve the patients remotely. For instance, Mount Sinai Health System is using MindMaze’s MindMotionGO platform, to track body movements of patients using optical motion-capture technology. It enables the therapist to monitor the motor recovery process. With the help of such technological solutions, the continuation of rehabilitation services during the pandemic is possible, while reducing the burden on hospitals and other facilities

Access Press Release@ https://www.grandviewresearch.com/press-release/us-skilled-nursing-facility-rehabilitation-market-analysis

U.S. Skilled Nursing Facility And Rehabilitation Market Segmentation

Grand View Research has segmented the U.S. skilled nursing facility and rehabilitation market on the basis of type of facility:

U.S. Skilled Nursing Facility And Rehabilitation Type of Facility Outlook (Revenue, USD Billion, 2016 - 2028)

• Freestanding
• Hospital

List of Key Players of U.S. Skilled Nursing Facility And Rehabilitation Market

• Brookdale Senior Living, Inc
• The Ensign Group, Inc
• Genesis Healthcare, Inc
• Extendicare
• Sunrise Senior Living, LLC
• ProMedica
• Golden Living Centers
• Life Care Centers of Amer

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Civil Aviation Industry Trends, Demand, Production, Analysis and Forecast to 2028: Grand View Research Inc.

 COVID-19 Impact On Civil Aviation Industry, Growth & Trends

The outbreak of the COVID-19 pandemic has taken a severe toll on the global civil aviation industry, which has had to confront considerable revenue losses over the past year. The industry is poised for a gradual recovery and is expected to reach USD 1.09 trillion by 2028, registering a CAGR of 8.9% from 2021 to 2028, according to a new report by Grand View Research, Inc. Airline operators took a drastic hit as several governments across the world imposed restrictions on the movement of people as part of the efforts to arrest the spread of coronavirus and people preferred keeping travel-related activities at bay owing to concerns over the risk of contraction of the disease. The demand for air travel continued to plummet as a result.

The initial response to the outbreak of the pandemic was limited to prohibiting travelers from China. However, with the rapid spread of coronavirus across the world, several governments went on to impose travel bans. The World Health Organization (WHO) coordinated with various governments to issue a global health advisory and urged people across the globe to avoid all travel activities. The subsequent dramatic decline in air passenger traffic following such containment measures poses a severe threat to numerous incumbents of the aviation industry.

At this juncture, airline operators are focusing aggressively on reviving themselves amid the challenging situation. Airlines are also focusing on regaining passengers' trust by ensuring sanitized cabins and guaranteeing touchless travel. At the same time, several governments worldwide are instilling cash in the aviation industry. Numerous airlines in the U.S. and the Gulf have already become solvent, even with reduced revenue inflows, leveraging the support they received from their respective governments.

Request a free sample copy or view report summary: COVID-19 Impact On Civil Aviation Industry Report

COVID-19 Impact On Civil Aviation Industry, Report Highlights

• Both domestic and international air passenger traffic plummeted approximately 60% over the year in 2020. However, domestic air travel is recovering ahead of international air travel as various governments are easing the restrictions on the movement of people and permitting domestic air travel
• Airlines are putting a strong emphasis on enhancing the traveling experience by implementing solutions based on the latest technologies, such as thermal scanning, biometric scanning, and UV ray disinfection
• Asia Pacific is expected to recover faster than other regional markets. The level of consumer confidence among passengers in the region has been improving as a result of the efforts being pursued by the governments in the region to contain the spread of coronavirus
• Operators, including American Airlines, Alaska Airlines, and South West Airlines, are adopting unique marketing plans to attract passengers as part of the efforts to augment the revenues

Access Press Release@ https://www.grandviewresearch.com/press-release/global-civil-aviation-industry

Civil Aviation Industry Segmentation

Grand View Research has segmented the global COVID-19 impact on civil aviation industry based on region:

COVID-19 Impact on Civil Aviation Regional Outlook (Revenue, USD Billion, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Microneedling Market to Witness Exponential Growth by 2028: Grand View Research Inc.

 Microneedling Market Growth & Trends

The global microneedling market size is expected to reach USD 992.49 million by 2028, registering a CAGR of 7.9% over the forecast period, according to a new report by Grand View Research, Inc. It is a minimally invasive aesthetic procedure that involves superficial and controlled puncturing (micro-puncturing) to the skin by using a rolling device embedded with small fine needles made of either metal or silicon and is performed under local anesthesia. According to NCBI, it was initially introduced for skin rejuvenation; however, recently it has been used for treating skin conditions like acne scar, post-traumatic burn, alopecia, stretch marks, hyperpigmentation, etc. due to the proven effectiveness of the treatment.

As stated by Healthline, microneedling, also known as collagen induction therapy, boosts the production of collagen in the epidermis by breaking down hardened scar strands and allows the epidermis to revascularize. The introduction of at-home devices like dermarollers (0.2 to 0.3mm) has further boosted the market growth. Moreover, factors like rising aesthetic consciousness among the population, high procedure effectiveness, lower costs as compared to other aesthetic procedures, and availability of at-home products are expected to propel market growth.

The COVID-19 pandemic has adversely affected the overall aesthetic industry along with this market, especially in the first and second quarters of 2020, due to restrictions on the elective aesthetic procedure. However, many dermatologists believe that COVID-19 may act as a springboard that will drastically increase patient footfall for aesthetic treatments post-pandemic. For instance, post-lockdown, the number of first-time attendees to dermatology clinics increased by 78% in the U.K. Moreover, the online sales of beauty tools and products including dermarollers increased during the pandemic.

Request a free sample copy or view report summary: Microneedling Market Report

Microneedling Market Report Highlights

• The RF microneedling product segment accounted for the highest revenue share in 2020 due to high demand for these products as they provide more prominent results and safety than manual procedures
• Dermapen segment accounted for the largest share of over 38% in 2020 and is expected to retain the leading position over the forecast period
• The skin rejuvenation application segment held the highest revenue share in 2020. Skin rejuvenation procedures are among the most frequently carried out minimally aesthetic procedures globally
• North America held the highest market share in 2020. However, Asia Pacific is expected to register the fastest CAGR over the forecast period due to the availability of skilled professionals, advanced techniques, and cheaper treatment costs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-microneedling-market

Microneedling Market Segmentation

Grand View Research has segmented the global microneedling market on the basis of type, product, needle material, application, and region:

Microneedling Type Outlook (Revenue, USD Million, 2016 - 2028)

• Laser
• RF

Microneedling Product Outlook (Revenue, USD Million, 2016 - 2028)

• Derma-stamp
• Dermapen
• Dermarollers

Microneedling Needle Material Outlook (Revenue, USD Million, 2016 - 2028)

• Silicon
• Metal
• Glass Hollow

Microneedling Application Outlook (Revenue, USD Million, 2016 - 2028)

• Skin Rejuvenation
• Acne Scar
• Traumatic & Surgical Scars
• Others

Microneedling Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Microneedling Market

• Lumenis
• Cutera
• Cynosure
• Endymed Medical
• Candela Medical
• Dermaconcepts
• Eclipse Aesthetics
• Dermaquip
• Lutronic
• Dermaroller GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Branched Stent Grafts Market Size Is Anticipated To Reach USD 477.53 Million by 2028

 Branched Stent Grafts Market Growth & Trends

The global branched stent grafts market size is anticipated to reach USD 477.53 million by 2028, registering a CAGR of 7.9% from 2021 to 2028, according to a new report by Grand View Research, Inc. Continued robust growth in segments is an outcome of the growing diagnostic capturing of pre-ruptured aneurysms, expanding clinical coverage, and an overarching trend for endovascular aneurysm repair. In addition, the preference for endovascular treatment for aortic aneurysms further boosts the market growth.

Around 28 million vascular surgeries have been postponed or canceled globally at the peak of the COVID-19 pandemic, which can seriously affect the market. Restrictions on the movement of goods and people gradually led to a decline in the uptake of nonelective surgeries, such as those resulting from trauma or acute conditions. In addition, extended factory closures by companies in several countries slowed down the manufacturing of products.

With the rapid increase in the elderly population worldwide, the frequency of aortic aneurysms is likely to increase, which, in turn, is expected to contribute to market growth during the forecast period. In the U.S., aortic aneurysms were the leading cause of 9,923 deaths in 2018. Thoracic aortic aneurysm and AAA are types of aortic aneurysms; aneurysms can also occur in other parts of the body.

The global market is fairly competitive. The most notable participants in the market are Medtronic, Terumo Corp., and Cardinal Health (Cordis). Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in March 2021, Medtronic collaborated with Spectrum Health to drive value in healthcare and improve outcomes for patients in West Michigan. In September 2020, Terumo Aortic launched the TREO Abdominal Aortic Stent-Graft System to expand the company’s aortic solutions offerings.

Request a free sample copy or view report summary: Branched Stent Grafts Market Report

Branched Stent Grafts Market Report Highlights

• Iliac stents are expected to grow at a CAGR of 5.9% during the forecast period owing to the high technological advancements in this segment
• The chimney segment is anticipated to grow at the fastest CAGR of more than 8% during the forecast period owing to the growing application scope of these products
• In 2021, North America held the dominant share of the global market owing to the increased burden of vascular diseases
• Asia Pacific is expected to be the fastest-growing regional market from 2021 to 2028 due to the growing presence of key companies, such as Microport Scientific Corp. and Medtronic, Inc., in the region
• Europe is expected to hold the second-largest market share by 2028 due to high disposable income levels, the presence of developed economies, and the availability of well-established healthcare infrastructure & skilled professionals

Access Press Release@ https://www.grandviewresearch.com/press-release/global-branched-stent-grafts-market

Branched Stent Grafts Market Segmentation

Grand View Research has segmented the global branched stent grafts market on the basis of type, application, and region:

Branched Stent Grafts Type Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)

• Iliac Stent
• Others

Branched Stent Grafts Application Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)

• EVAR
  • FEVAR
  • Chimney
  • Others

Branched Stent Grafts Regional Outlook (Volume, Units; Revenue, USD Million, 2021 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Greece
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Branched Stent Grafts Market

• Medtronic
• Biotronik
• Alvimedica
• Endocor GmbH
• Eucatech AG
• Merit Medical Systems
• Abbott
• Cook Medical
• Cardinal Health (Cordis)
• Boston Scientific Corp.
• Terumo Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopsy Guidance System Market Estimated to Experience a Hike in Growth by 2028: Grand View Research Inc.

 Biopsy Guidance System Market Growth & Trends

The global biopsy guidance system market size is expected to reach USD 1,383.5 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.2% from 2021 to 2028. The increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and impact of COVID-19 are the key driving factors for the market.

A biopsy is one of the most prominent procedures for diagnosing cancer amongst other chronic diseases, and it is commonly employed in the diagnosis of breast, brain, skin, and prostate cancer. The increasing prevalence of cancer is a major factor responsible for market growth. For instance, according to Cancer.org, in 2021, around 1.9 million new cancer cases are expected to be diagnosed in the US. Since the biopsy guidance system is one of the major requirements for the initial diagnosis of cancer, thus, rising number of cancer cases is anticipated to propel market growth over the forecast period

Furthermore, there is a rising preference for minimally invasive biopsy treatments in the market. During the forecast period, several types of technologies and products including robot-assisted biopsy guidance systems, needle-based biopsy guns, and vacuum-assisted core biopsy systems, are expected to expand rapidly. For instance, in March 2021, IZI Medical Products, LLC launched Quick-Core Auto Biopsy System for soft tissue biopsy. It is a lightweight, completely automatic biopsy device and provides reliability, quality, and accuracy. Additionally, rising awareness of breast cancer treatment and diagnosis will further boost market growth over the forecast period.

Request a free sample copy or view report summary: Biopsy Guidance System Market Report

Biopsy Guidance System Market Report Highlights

• In terms of product, the stereotactic guided biopsy segment held the largest revenue share in 2020 and the ultrasound-guided biopsy segment is estimated to be the fastest-growing segment over the forecast period
• In terms of application, the brain biopsy segment held the largest revenue share in 2020 and the breast biopsy segment is estimated to be the fastest-growing segment during the forecast period. The rising prevalence of brain cancer is the major factor driving the demand for brain biopsies
• In terms of end-use, the hospital segment held the largest revenue share in 2020. The hospital segment's dominance is majorly attributed to the higher biopsy guiding system utilization in hospitals
• North America dominated the market in 2020 owing to numerous factors such as enhanced infrastructure, rising patient awareness, and the presence of key players in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopsy-guidance-systems-market

Biopsy Guidance System Market Segmentation

Grand View Research has segmented the global biopsy guidance system market on the basis of product, application, end-use, and region:

Biopsy Guidance System Product Outlook (Revenue, USD Million, 2016 - 2028)

• Stereotactic Guided Biopsy
• Ultrasound Guided Biopsy
• MRI Guided Biopsy

Biopsy Guidance System Application Outlook (Revenue, USD Million, 2016 - 2028)

• Brain Biopsy
• Breast Biopsy
• Other Applications

Biopsy Guidance System End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Research and Academic Institutes

Biopsy Guidance System Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Biopsy Guidance System Market

• Becton, Dickinson, and Company
• Hologic, Inc.
• Devicor Medical Products, Inc.
• Braun Melsungen AG
• ARGON MEDICAL
• Boston Scientific Corporation
• INRAD Inc.
• Cook Medical
• PLANMED OY

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Cancer Biopsy Market Predicted to Witness Steady Growth During the Forecast Period

 U.S. Cancer Biopsy Market Growth & Trends

The U.S. cancer biopsy market size is expected to reach USD 15.98 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.0% from 2021 to 2028. The increasing usage of technologically advanced devices for the early detection of diseases is one of the key factors driving the market.

A significant transaction from tumor to liquid biopsy is anticipated to increase the adoption of this technique in the market. Acknowledging this trend, several operating entities have undertaken various initiatives to expand their biopsy kits portfolio. For instance, in June 2021, Biocept, Inc. and Quest Diagnostics collaborated to offer NGS-based liquid biopsy testing for lung cancer diagnosis.

Furthermore, supportive regulatory and reimbursement scenarios in the country have supplemented the market growth. The U.S. FDA is actively engaged in supporting the commercialization of cancer biopsy products and increasing the use of these assays in clinics. For instance, in March 2021, the U.S. FDA granted a breakthrough device designation to RaDaR-a liquid biopsy assay to detect minimal residual disease in early-stage cancer.

Request a free sample copy or view report summary: U.S. Cancer Biopsy Market Report

U.S. Cancer Biopsy Market Report Highlights

• The fine-needle aspiration type segment accounted for the largest revenue share in 2020 owing to it being a well-established approach for the initial diagnosis of most of the body lesions. Among various biopsy techniques, fine-needle aspiration has witnessed significant popularity in diagnostics
• By type, the others segment is expected to expand at the fastest CAGR of 15.2% from 2021 to 2028. Liquid biopsies are anticipated to witness considerable growth over the forecast period due to the advancements and increasing regulatory approvals in the U.S.
• Screening and monitoring emerged as a dominant application segment in 2020. Follow-up or repeat biopsy procedures are fueling the growth of this segment
• Key players are collaborating with biopharma developers to support their product development process

Access Press Release@ https://www.grandviewresearch.com/press-release/us-cancer-biopsy-market-analysis

U.S. Cancer Biopsy Market Segmentation

Grand View Research has segmented the U.S. cancer biopsy market on the basis of type, application, and site (organ):

U.S. Cancer Biopsy Type Outlook (Revenue, USD Million, 2017 - 2028)

• Fine-needle Aspiration
  • Pharma-use
  • Clinical-use
• Core Biopsy
  • Pharma-use
  • Clinical-use
• Surgical Biopsy
  • Pharma-use
  • Clinical-use
• Skin Biopsy /Punch Biopsy
  • Pharma-use
  • Clinical-use
• Others
  • Pharma-use
  • Clinical-use

U.S. Cancer Biopsy Application Outlook (Revenue, USD Million, 2017 - 2028)

• Screening & Monitoring
• Diagnostics
• Investigational & Translational Research
• Pharma & Biopharma Discovery & Development

U.S. Cancer Biopsy Site (Organ) Outlook (Revenue, USD Million, 2017 - 2028)

• Liver
• Breast
• Thyroid
• Prostate Gland
• Uterus & Cervix
• Kidney
• Bladder
• Lungs
• Pancreas
• Others

List of Key Players of U.S. Cancer Biopsy Market

• Becton, Dickinson and Company
• IZI Medical Products
• Johnson & Johnson
• Argon Medical
• Cook Medical
• Spectra Medical Devices, Inc.
• Medtronic plc.
• Boston Scientific Corporation
• Conmed Corporation
• INRAD, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Joint Replacement Market During 2021 – 2028 to Gain Robust Traction: Grand View Research Inc.

 Joint Replacement Market Growth & Trends

The global joint replacement market size is expected to reach USD 25.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.4% from 2021 to 2028. The growing incidence of orthopedic diseases and the increasing number of the target population are boosting the market growth.

According to the Centers for Disease Control and Prevention, 1 in every 4 adults in the U.S. is suffering from arthritis in 2019. In addition, it is projected that by 2040, approximately 78 million of the U.S. adult citizens aged 18 years or older will suffer from arthritis diagnosed by doctors. This upsurge in the number of patients suffering from arthritis is increasing the number of joint replacement surgeries.

Moreover, the increasing demand for minimally invasive joint replacement operations is likely to propel the market over the forecast period. In addition, growing awareness about day surgeries, increasing healthcare reimbursement, and rapid adoption of advanced technologies are some of the key factors expected to contribute to market growth over the coming years. The COVID 19 had negatively impacted the market in 2020. However, it started recovering during the third quarter of 2020 and is expected to pace up in the coming years.

Request a free sample copy or view report summary: Joint Replacement Market Report

Joint Replacement Market Report Highlights

• The knee replacement was the largest revenue-generating segment of the market in 2020. This contribution is mainly because of the increased demand for these surgeries and continuous technological advancements
• The cemented fixation segment dominated the market and accounted for the largest revenue share of over 49.0% in 2020. The associated advantages such as its low revision rate, better acceptance, lesser hospital stay among others are boosting segment growth
• The total replacement segment held the largest revenue share of over 64.0% in 2020. The growth can be attributed to the increased number of this kind of surgery and continuous technological advancements by the leading industry players
• The hospitals held the largest revenue share in 2020. The growth can be attributed to advanced treatment options and a large number of patient footfalls
• North America dominated the market in the year 2020. The growing target population and favorable reimbursement policies along with the advanced healthcare infrastructure are anticipated to contribute to market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-joint-replacement-market

Joint Replacement Market Segmentation

Grand View Research has segmented the global joint replacement market on the basis of product, fixation type, end-use, procedure, and region:

Joint Replacement Product Outlook (Revenue, USD Million, 2016 - 2028)

• Knees
• Hips
• Extremities
  • Upper
  • Lower

Joint Replacement Fixation Type Outlook (Revenue, USD Million, 2016 - 2028)

• Cemented
• Cementless
• Hybrid
• Reverse Hybrid

Joint Replacement End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Orthopedic Clinics
• Others

Joint Replacement Procedure Outlook (Revenue, USD Million, 2016 - 2028)

• Total Replacement
• Partial Replacement
• Others

Joint Replacement Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Joint Replacement Market

• Johnson & Johnson Services, Inc. (DePuy Synthes)
• Stryker
• Zimmer Biomet
• Smith+Nephew
• DJO, LLC
• Arthrex, Inc.
• Exactech, Inc.
• Conformis
• MicroPort Orthopedics
• Corin Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Zero Trust Security Market Poised to Expand at a Robust Pace of USD 59.43 Billion Over 2028: Grand View Research Inc.

 Zero Trust Security Market Growth & Trends

The global zero trust security market size is expected to reach USD 59.43 billion by 2028, registering a CAGR of 15.2% from 2021 to 2028, according to a new study conducted by Grand View Research, Inc. The market is driven by the need to protect enterprise digital environments by averting lateral movement, leveraging network segmentation, simplifying granular user-access control, and implementing layer 7 threat prevention. The robust solutions for implementing a zero-trust security environment ensure the protection of computers, programs, and networks from unauthorized access. Moreover, preventing unwarranted access to critical data, as the adoption of technologies, such as cloud computing, Wi-Fi, and Internet of Things (IoT), coupled with outsourcing service, is increasing, is driving the growth of the market. The COVID-19 pandemic has further acted as a catalyst for market growth with enterprises investing in securing their networks, endpoints, and IT infrastructure with a zero-trust security framework.

The threat to digitally stored information from unauthorized access is also driven by changing technological landscape. While technology revolutionizes a business process, it also creates vulnerabilities in online protected data. In addition, while internet connectivity improves the operational task of the business by speeding up the process and improving accessibility, the risk of cyber attacks also increases rapidly. Moreover, the rapid expansion of operational data exposed to cyber adversaries through mobile, other edge devices, and IOT and the dependence of companies on third-party vendors and service providers are some of the prevailing supply chain trends increasing the risk of cyberattacks to access information. Therefore, the implementation of a security solution ensures a zero-trust security environment in the organization to mitigate the risks arising from various business activities and internet connectivity.

The application of the zero trust model is parallel to the concept of cybersecurity as it focuses on preventing intrusion by securing the digital network. Several countries across the world introduced laws to prevent cybercrime and data theft, which is vital for safeguarding the BFSI, IT, telecom, defense, and healthcare, other major sectors. The increasing internal and external threat of unauthorized data accessibility and cybercrime due to the political and personal interest of hackers or intruders for earning easy money further pressurizes governments to update their policies regularly. For instance, China updated its cyber policy on December 1, 2019, which instructs both Chinese and foreign public as well as private companies and organizations to secure their networks. The cyber law in the U.S. varies based on the business sector and includes Health Insurance Portability and Accountability Act, 2002 (HIPAA); Homeland Security Act that also includes Federal Information Security Management Act (FISMA), and 1996 Gramm-Leach-Billey Act. Such cyber laws further necessitate the need to secure networking structure and boost the demand for authentication and cyber-solution that ensures a zero-trust security environment.

Request a free sample copy or view report summary: Zero Trust Security Market Report

Zero Trust Security Market Report Highlights

• The Small and Medium Enterprises (SMEs) segment is anticipated to witness the fastest CAGR over the forecast period owing to increasing awareness and threat of unauthorized access during cyber attacks
• The multi-factor authentication segment led the global market in 2020 and will expand further at the fastest CAGR from 2021 to 2028
• The growth can be attributed to the need to overcome the challenges of revenue loss and data loss risks in the era of confidential and vulnerable data, as multi-factor authentication presents multiple layers of identity verification to grant access to an authorized individual
• North America led the global market in 2020 and will remain dominant even during the forecast years
• The growth is credited to the high-security investment from the large enterprises across the regional industries, such as BFSI, that are at constant risk of cyber attacks as well as internal fraudsters

Access Press Release@ https://www.grandviewresearch.com/press-release/global-zero-trust-security-market

Zero Trust Security Market Segmentation

Grand View Research has segmented the global zero trust security market on the basis of security type, deployment, organization size, authentication, application area, and region:

Zero Trust Security Type Outlook (Revenue, USD Million, 2017 - 2028)

• Network
• Data
• Endpoint
• Cloud
• Others

Zero Trust Security Deployment Outlook (Revenue, USD Million, 2017 - 2028)

• On-premises
• Cloud

Zero Trust Security Organization Size Outlook (Revenue, USD Million, 2017 - 2028)

• SMEs
• Large Enterprise

Zero Trust Security Authentication Outlook (Revenue, USD Million, 2017 – 2028)

• Single-factor Authentication
• Multi-factor Authentication

Zero Trust Security Application Area Outlook (Revenue, USD Million, 2017 - 2028)

• IT & Telecom
• BFSI
• Healthcare
• Retail
• Others

Zero Trust Security Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• MEA

List of Key Players of Zero Trust Security Market

• Cisco Systems, Inc.
• Akamai Technologies
• Palo Alto Networks
• Check Point Software Technologies
• Trend Micro, Inc.
• IBM Corp.
• Symantec Corp.
• FireEye, Inc.
• McAfee Corp.
• Forcepoint
• Microsoft Corp.
• VMWare, Inc.
• Fortinet
• Cloudflare, Inc.
• SonicWall

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.